Key result
First CVD event in type 2 diabetes linked to ~2.2-fold higher recurrent CVD risk.
Why the study?
The incremental risks of cardiovascular disease after a first cardiovascular event in patients with type 2 diabetes remain unclear because assessing risk changes from the pre-event to the post-event period is difficult.
Does experiencing a first cardiovascular event increase the risk of recurrent cardiovascular events and all-cause mortality compared with the pre-event period in patients with type 2 diabetes?
Cohort (n=2,535)
Does experiencing a first cardiovascular event increase the risk of recurrent cardiovascular events and all-cause mortality compared with the pre-event period in patients with type 2 diabetes?
Patients with type 2 diabetes who experience a first cardiovascular event face a twofold increased risk of subsequent cardiovascular events and all-cause mortality, with higher mortality observed after ischemic stroke than coronary artery disease.
Answers are grounded in this paper and cite their sources.
May support intensified post-event monitoring in T2D; leaves open optimal prevention strategies pending randomized trials.
The incremental risks of cardiovascular disease (CVD) after the first CVD event remain unclear because of the difficulty of assessing how risks changed from the pre-event to the post-event period. A long-term follow-up study was conducted in patients with type 2 diabetes. The endpoints were CVD, defined as ischemic stroke (IS) or coronary artery disease (CAD), and all-cause mortality. Two cohorts were defined: the pre-event and post-event cohorts. The incidence was analyzed using the Kaplan–Meier method, and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards models. The post-event cohort was further stratified by the type of the first event (IS or CAD). Among 2535 participants, 317 had a first CVD event, and 293 were included in the post-event cohort. Compared with the pre-event cohort, the post-event cohort had significantly higher risks of recurrent CVD (adjusted HR 2.24, 95% CI 1.63–3.06) and all-cause mortality (adjusted HR 2.07, 95% CI 1.59–2.69). Within the post-event cohort, recurrent CVD risk showed no difference between the IS and CAD groups, but all-cause mortality was significantly higher in the IS group. Patients with type 2 diabetes who experienced a first CVD event had a twofold increased risk of recurrent CVD events and all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Kuroki et al. (2026) conducted a cohort in Type 2 diabetes (n=2,535). First cardiovascular disease event (ischemic stroke or coronary artery disease) vs. Pre-event cohort (prior to first cardiovascular disease event) was evaluated on Cardiovascular disease (ischemic stroke or coronary artery disease) (HR 2.24, 95% CI 1.63-3.06). Experiencing a first CVD event in type 2 diabetes increased the risk of recurrent CVD and all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: